Cleared Traditional

K153281 - BrightMatter Guide with Surface Trace Registration

K153281 is an FDA 510(k) clearance for BrightMatter Guide with Surface Trace R..., manufactured by Synaptive Medical, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K153281 · Synaptive Medical, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
139d
Days
Class 2
Risk

K153281 is an FDA 510(k) clearance for the BrightMatter Guide with Surface Trace Registration. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Synaptive Medical, Inc. (Toronto, CA). The FDA issued a Cleared decision on March 30, 2016 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Synaptive Medical, Inc. devices

FDA 510(k) Submission Details - K153281

510(k) Number K153281 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2015
Decision Date March 30, 2016
Days to Decision 139 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 149d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 387
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K153281.
EXACTECH GPS
K152764 · Blue Ortho · Jul 2016
BrightMatter Guide with BrightMatter Pointer
K160523 · Synaptive Medical, Inc. · Jun 2016
Fiagon Navigation System
K151156 · Fiagon GmbH · Apr 2016
ClearPoint System
K160434 · Mri Interventions, Inc. · Mar 2016
Leksell Stereotactic System, Injection/ Aspiration Needle Kit
K152558 · Elekta Instrument AB · Mar 2016
ROSA Brain
K151359 · Medtech S.A · Dec 2015